Cargando…

Quantifying the COVID19 infection risk due to droplet/aerosol inhalation

The dose-response model has been widely used for quantifying the risk of infection of airborne diseases like COVID-19. The model has been used in the room-average analysis of infection risk and analysis using passive scalars as a proxy for aerosol transport. However, it has not been employed for ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Bale, Rahul, Iida, Akiyoshi, Yamakawa, Masashi, Li, ChungGang, Tsubokura, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249924/
https://www.ncbi.nlm.nih.gov/pubmed/35778513
http://dx.doi.org/10.1038/s41598-022-14862-y
_version_ 1784739696427925504
author Bale, Rahul
Iida, Akiyoshi
Yamakawa, Masashi
Li, ChungGang
Tsubokura, Makoto
author_facet Bale, Rahul
Iida, Akiyoshi
Yamakawa, Masashi
Li, ChungGang
Tsubokura, Makoto
author_sort Bale, Rahul
collection PubMed
description The dose-response model has been widely used for quantifying the risk of infection of airborne diseases like COVID-19. The model has been used in the room-average analysis of infection risk and analysis using passive scalars as a proxy for aerosol transport. However, it has not been employed for risk estimation in numerical simulations of droplet dispersion. In this work, we develop a framework for the evaluation of the probability of infection in droplet dispersion simulations using the dose-response model. We introduce a version of the model that can incorporate the higher transmissibility of variant strains of SARS-CoV2 and the effect of vaccination in evaluating the probability of infection. Numerical simulations of droplet dispersion during speech are carried out to investigate the infection risk over space and time using the model. The advantage of droplet dispersion simulations for risk evaluation is demonstrated through the analysis of the effect of ambient wind, humidity on infection risk, and through a comparison with risk evaluation based on passive scalars as a proxy for aerosol transport.
format Online
Article
Text
id pubmed-9249924
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92499242022-07-03 Quantifying the COVID19 infection risk due to droplet/aerosol inhalation Bale, Rahul Iida, Akiyoshi Yamakawa, Masashi Li, ChungGang Tsubokura, Makoto Sci Rep Article The dose-response model has been widely used for quantifying the risk of infection of airborne diseases like COVID-19. The model has been used in the room-average analysis of infection risk and analysis using passive scalars as a proxy for aerosol transport. However, it has not been employed for risk estimation in numerical simulations of droplet dispersion. In this work, we develop a framework for the evaluation of the probability of infection in droplet dispersion simulations using the dose-response model. We introduce a version of the model that can incorporate the higher transmissibility of variant strains of SARS-CoV2 and the effect of vaccination in evaluating the probability of infection. Numerical simulations of droplet dispersion during speech are carried out to investigate the infection risk over space and time using the model. The advantage of droplet dispersion simulations for risk evaluation is demonstrated through the analysis of the effect of ambient wind, humidity on infection risk, and through a comparison with risk evaluation based on passive scalars as a proxy for aerosol transport. Nature Publishing Group UK 2022-07-01 /pmc/articles/PMC9249924/ /pubmed/35778513 http://dx.doi.org/10.1038/s41598-022-14862-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bale, Rahul
Iida, Akiyoshi
Yamakawa, Masashi
Li, ChungGang
Tsubokura, Makoto
Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
title Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
title_full Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
title_fullStr Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
title_full_unstemmed Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
title_short Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
title_sort quantifying the covid19 infection risk due to droplet/aerosol inhalation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249924/
https://www.ncbi.nlm.nih.gov/pubmed/35778513
http://dx.doi.org/10.1038/s41598-022-14862-y
work_keys_str_mv AT balerahul quantifyingthecovid19infectionriskduetodropletaerosolinhalation
AT iidaakiyoshi quantifyingthecovid19infectionriskduetodropletaerosolinhalation
AT yamakawamasashi quantifyingthecovid19infectionriskduetodropletaerosolinhalation
AT lichunggang quantifyingthecovid19infectionriskduetodropletaerosolinhalation
AT tsubokuramakoto quantifyingthecovid19infectionriskduetodropletaerosolinhalation